Leidos announced it will release its third quarter 2026 financial results on November 3, 2026, for the period ending October 2, 2026. The company will issue its earnings press release before hosting a conference call at 8 a.m. ET the same day, which will be available live and as a replay on their investor relations website. Leidos, a leader in technology and government services, reported $17.2 billion in revenue for fiscal year 2025. Investors can access the webcast until November 3, 2027, providing ample time to review the results and company outlook.
Leidos' upcoming third quarter 2026 earnings call is scheduled for November 3, 2026. For readers following the Industrials sector, here is Pluang's market snapshot as of Oct 06, 2026 18:13 WIB: out of 93 priced US Industrials stocks tradable on Pluang, 65 rose and 22 fell. Notable movers include TRMD at USD 39.95 with a 1-day change of -2.68% and a typical hold time of 23 days, PL at USD 17.78 up 2.42% with a 3-day hold time and 96% buy order activity, and JBLU at USD 4.14 up 1.97% with a 44-day hold time and 70% buy order activity.
Over the past six months, Costco's stock has fallen by 10%, contrasting with the S&P 500's 17% gain. This decline has sparked debate on whether Costco's shares, now trading under $900, represent a buying opportunity. Investors are weighing if the pri...
Allstate has opened the Auto Lab at its Claims University in Dallas, a hands-on training center where claims adjusters work with 22 vehicles and four motorcycles, including electric, hybrid, and gas-powered models. The lab uses real damaged vehicles ...
1911 Gold Corp reported high-grade gold drill results extending the 710-711 and 007 zones at its True North Gold Project in Manitoba. Highlights include 32.40 g/t gold over 1.10 meters from underground drilling 720 meters below surface. The results s...
Citi has increased its target price for AstraZeneca to £186 from £178, maintaining a 'buy' rating after positive clinical developments, especially for the drug tozorakimab. The broker raised peak sales forecasts for tozorakimab to $7 billion and SERE...
Apple's stock surged nearly 1200% over the last decade, turning $10,000 into about $129,600. However, with its market cap near $5 trillion, future growth is expected to slow. Models project a $10,000 investment today could grow to around $16,494 by 2...
